Novartis Investigative Site

Summary

Novartis Investigative Site is a medical facility located in OTTAWA, Ontario. This center is recognized for care of Multiple Sclerosis, Breast Cancer, Cancer, Chronic Urticaria, Relapse and other specialties. Novartis Investigative Site is involved with conducting 82 clinical trials across 103 conditions. There are 0 research doctors associated with this hospital, such as .

Top PIs

Clinical Trials running at Novartis Investigative Site

Multiple Sclerosis

Motor and sensory neuropathy

Breast Cancer

Relapse

Acute Lymphoblastic Leukemia

Myasthenia Gravis

Prostate Cancer

Breast cancer

Diffuse Large B-Cell Lymphoma

Lymphoma

Ofatumumab

for Multiple Sclerosis

The exploratory ELIOS study aims to assess the value of novel investigational Eye Movement Biomarkers (EMBs) in tracking disease-related changes among a real-world cohort of Canadian patients with active RRMS, within the context of disease-modifying treatment (i.e., ofatumumab). To that end, the study will use the patented investigational, Eye Tracking Neurological Assessment (ETNA-ProgMS) SaMD (v1.0.11 or later), which has not yet received Health Canada approval, to reliably and accurately track eye movements with precision.

Recruiting

3 awards

Phase 4

2 criteria

Remibrutinib vs Teriflunomide

for Multiple Sclerosis

This trial compares two medications, remibrutinib and teriflunomide, for treating patients with relapsing multiple sclerosis. These patients have repeated episodes of symptoms and need effective treatments. The medications work by controlling the immune system to prevent it from causing damage to the nervous system. Teriflunomide is an approved medication for adults with relapsing multiple sclerosis.

Recruiting

2 awards

Phase 3